vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and REGIS CORP (RGS). Click either name above to swap in a different company.

REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). REGIS CORP runs the higher net margin — 0.8% vs -26.0%, a 26.8% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs -23.3%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $-9.2M). Over the past eight quarters, REGIS CORP's revenue compounded faster (7.8% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.

PETS vs RGS — Head-to-Head

Bigger by revenue
RGS
RGS
1.4× larger
RGS
$57.1M
$40.7M
PETS
Growing faster (revenue YoY)
RGS
RGS
+45.5% gap
RGS
22.3%
-23.3%
PETS
Higher net margin
RGS
RGS
26.8% more per $
RGS
0.8%
-26.0%
PETS
More free cash flow
RGS
RGS
$10.1M more FCF
RGS
$891.0K
$-9.2M
PETS
Faster 2-yr revenue CAGR
RGS
RGS
Annualised
RGS
7.8%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
PETS
PETS
RGS
RGS
Revenue
$40.7M
$57.1M
Net Profit
$-10.6M
$456.0K
Gross Margin
23.3%
Operating Margin
-25.7%
10.8%
Net Margin
-26.0%
0.8%
Revenue YoY
-23.3%
22.3%
Net Profit YoY
-1392.6%
-94.0%
EPS (diluted)
$-0.50
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
RGS
RGS
Q4 25
$40.7M
$57.1M
Q3 25
$44.4M
$59.0M
Q2 25
$51.2M
$60.4M
Q1 25
$50.8M
$57.0M
Q4 24
$52.0M
$46.7M
Q3 24
$58.0M
$46.1M
Q2 24
$66.2M
$49.4M
Q1 24
$65.1M
$49.2M
Net Profit
PETS
PETS
RGS
RGS
Q4 25
$-10.6M
$456.0K
Q3 25
$-8.5M
$1.4M
Q2 25
$-34.2M
$116.5M
Q1 25
$-11.6M
$250.0K
Q4 24
$-707.0K
$7.6M
Q3 24
$2.3M
$-853.0K
Q2 24
$3.8M
$91.2M
Q1 24
$-5.0M
$-2.3M
Gross Margin
PETS
PETS
RGS
RGS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
RGS
RGS
Q4 25
-25.7%
10.8%
Q3 25
-18.9%
10.0%
Q2 25
-66.7%
12.1%
Q1 25
-11.9%
8.8%
Q4 24
-0.9%
11.8%
Q3 24
1.0%
4.6%
Q2 24
6.6%
Q1 24
-5.9%
8.3%
Net Margin
PETS
PETS
RGS
RGS
Q4 25
-26.0%
0.8%
Q3 25
-19.2%
2.3%
Q2 25
-66.7%
192.9%
Q1 25
-22.9%
0.4%
Q4 24
-1.4%
16.4%
Q3 24
4.0%
-1.9%
Q2 24
5.7%
184.7%
Q1 24
-7.7%
-4.7%
EPS (diluted)
PETS
PETS
RGS
RGS
Q4 25
$-0.50
$0.16
Q3 25
$-0.41
$0.49
Q2 25
$-1.65
$43.67
Q1 25
$-0.56
$0.08
Q4 24
$-0.03
$2.71
Q3 24
$0.11
$-0.36
Q2 24
$0.18
$38.40
Q1 24
$-0.24
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
RGS
RGS
Cash + ST InvestmentsLiquidity on hand
$26.9M
$18.4M
Total DebtLower is stronger
$113.3M
Stockholders' EquityBook value
$32.8M
$188.7M
Total Assets
$88.0M
$588.3M
Debt / EquityLower = less leverage
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
RGS
RGS
Q4 25
$26.9M
$18.4M
Q3 25
$36.1M
$16.6M
Q2 25
$41.1M
$17.0M
Q1 25
$54.7M
$13.3M
Q4 24
$50.1M
$10.2M
Q3 24
$52.0M
$6.3M
Q2 24
$46.0M
$10.1M
Q1 24
$55.3M
$5.9M
Total Debt
PETS
PETS
RGS
RGS
Q4 25
$113.3M
Q3 25
$111.3M
Q2 25
$110.8M
Q1 25
$112.0M
Q4 24
$111.5M
Q3 24
$95.2M
Q2 24
$99.5M
Q1 24
$179.7M
Stockholders' Equity
PETS
PETS
RGS
RGS
Q4 25
$32.8M
$188.7M
Q3 25
$43.1M
$187.6M
Q2 25
$51.5M
$185.6M
Q1 25
$85.1M
$68.6M
Q4 24
$96.2M
$66.7M
Q3 24
$96.4M
$56.4M
Q2 24
$93.5M
$56.8M
Q1 24
$96.7M
$-35.8M
Total Assets
PETS
PETS
RGS
RGS
Q4 25
$88.0M
$588.3M
Q3 25
$100.3M
$592.1M
Q2 25
$109.8M
$599.0M
Q1 25
$148.7M
$511.2M
Q4 24
$144.8M
$530.1M
Q3 24
$146.0M
$508.9M
Q2 24
$152.7M
$530.5M
Q1 24
$169.9M
$543.7M
Debt / Equity
PETS
PETS
RGS
RGS
Q4 25
0.60×
Q3 25
0.59×
Q2 25
0.60×
Q1 25
1.63×
Q4 24
1.67×
Q3 24
1.69×
Q2 24
1.75×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
RGS
RGS
Operating Cash FlowLast quarter
$-9.2M
$1.7M
Free Cash FlowOCF − Capex
$-9.2M
$891.0K
FCF MarginFCF / Revenue
-22.7%
1.6%
Capex IntensityCapex / Revenue
0.1%
1.4%
Cash ConversionOCF / Net Profit
3.65×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
RGS
RGS
Q4 25
$-9.2M
$1.7M
Q3 25
$-2.2M
$2.3M
Q2 25
$-12.3M
$6.8M
Q1 25
$7.0M
$6.2M
Q4 24
$-1.2M
$2.1M
Q3 24
$7.4M
$-1.3M
Q2 24
$-8.5M
$5.1M
Q1 24
$7.1M
$-277.0K
Free Cash Flow
PETS
PETS
RGS
RGS
Q4 25
$-9.2M
$891.0K
Q3 25
$-4.8M
$1.9M
Q2 25
$-13.6M
$6.2M
Q1 25
$4.6M
$5.9M
Q4 24
$-1.9M
$1.7M
Q3 24
$6.1M
$-1.4M
Q2 24
$-9.2M
$5.1M
Q1 24
$5.9M
$-326.0K
FCF Margin
PETS
PETS
RGS
RGS
Q4 25
-22.7%
1.6%
Q3 25
-10.8%
3.2%
Q2 25
-26.5%
10.3%
Q1 25
9.1%
10.3%
Q4 24
-3.7%
3.6%
Q3 24
10.6%
-3.0%
Q2 24
-13.9%
10.3%
Q1 24
9.0%
-0.7%
Capex Intensity
PETS
PETS
RGS
RGS
Q4 25
0.1%
1.4%
Q3 25
5.9%
0.7%
Q2 25
2.5%
0.9%
Q1 25
4.7%
0.6%
Q4 24
1.5%
0.9%
Q3 24
2.2%
0.0%
Q2 24
1.0%
0.0%
Q1 24
1.9%
0.1%
Cash Conversion
PETS
PETS
RGS
RGS
Q4 25
3.65×
Q3 25
1.68×
Q2 25
0.06×
Q1 25
24.80×
Q4 24
0.28×
Q3 24
3.18×
Q2 24
-2.27×
0.06×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

RGS
RGS

Franchise Segment$37.9M66%
Royalty$13.6M24%
Other$2.8M5%
Fees$1.8M3%
Franchise Fees$1.0M2%

Related Comparisons